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the relationship between 
insecticide resistance, mosquito 
age and malaria prevalence in 
Anopheles gambiae s.l. from Guinea
emma Collins1, Natasha M. Vaselli1, Moussa sylla2, Abdoul H. Beavogui2, James orsborne1, 
Gena Lawrence3, Ryan e. Wiegand3, seth R. Irish3,4, thomas Walker  1 & Louisa A. Messenger  3,5
Insecticide resistance across sub-Saharan Africa may impact the continued effectiveness of malaria 
vector control. We investigated the association between carbamate and pyrethroid resistance with 
Anopheles gambiae s.l. parity, Plasmodium falciparum infection, and molecular insecticide resistance 
mechanisms in Guinea. Pyrethroid resistance was intense, with field populations surviving ten times the 
insecticidal concentration required to kill susceptible individuals. The L1014F kdr-N1575Y haplotype 
and I1527T mutation were significantly associated with mosquito survival following permethrin 
exposure (prevalence Ratio; pR = 1.92, CI = 1.09–3.37 and PR = 2.80, CI = 1.03–7.64, respectively). 
partial restoration of pyrethroid susceptibility following synergist pre-exposure suggests a role for 
mixed-function oxidases. Carbamate resistance was lower and significantly associated with the G119S 
Ace-1 mutation. Oocyst rates were 6.8% and 4.2% among resistant and susceptible mosquitoes, 
respectively; survivors of bendiocarb exposure were significantly more likely to be infected. Pyrethroid 
resistant mosquitoes had significantly lower parity rates than their susceptible counterparts (PR = 1.15, 
CI = 1.10–1.21). Our findings emphasize the need for additional studies directly assessing the influence 
of insecticide resistance on mosquito fitness.
Malaria remains a leading cause of morbidity and mortality in the tropics, where it is estimated to have resulted 
in ~445,000 deaths in 2016 alone1. Despite considerable reductions in disease burden achieved by scaling-up the 
provision of long-lasting insecticidal nets (LLINs) and indoor residual spraying (IRS)2, long-term effectiveness of 
both strategies may be jeopardized by widespread emergence of insecticide resistance in mosquito populations3,4. 
In response, commercial manufacturers are developing alternate vector control interventions, as well as opti-
mizing use of existing insecticides through combinations and improved formulations. National Malaria Control 
Programmes (NMCPs) and international policy makers are also taking action to expand resistance monitoring 
and surveillance5. However, the severity of this threat is currently unknown because there is limited evidence 
linking the operational failure of available control measures to the presence of resistant mosquito species6–14.
The efficacy of IRS and LLINs is predicated on their ability to reduce the daily survival rate of Anopheles 
mosquitoes and prevent the completion of parasite development to the infectious stage. One explanation for the 
sustained effectiveness of LLINs, even in the presence of increased vector tolerance to their insecticidal prop-
erties, is that intact nets provide a physical barrier to mosquito feeding. A meta-analysis of field data indicated 
that treated nets reduced blood feeding and increased mosquito mortality compared to untreated nets, even in 
areas with the highest levels of resistance4. Furthermore, a recent large-scale, multi-country trial reported no 
association between malaria disease burden and pyrethroid resistance, with evidence that LLINs continued to 
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provide personal protection across areas of different resistance intensities15. Laboratory studies now suggest that 
fitness costs associated with insecticide resistance may influence malaria transmission either by directly reducing 
mosquito life span16 and/or fecundity17, altering host seeking, feeding and mating behaviours18–20 or by impairing 
parasite development inside vectors21–23. However, to date, few field studies have directly investigated the impact 
of insecticide resistance intensity on malaria transmission dynamics.
In Guinea, malaria is a serious public health problem, where the entire population of ~11.7 million people is at 
risk and the nationwide prevalence is estimated at 15%24. Between 2013–2017, the NMCP, with support from the 
President’s Malaria Initiative (PMI) and the Global Fund, have procured and distributed over 27.6 million pyre-
throid LLINs25. Because the current vector control strategy relies almost exclusively on LLIN use26, nationwide 
pyrethroid resistance is of concern27. To better inform future malaria control efforts in Guinea, there is a need to 
characterize levels of operationally-significant insecticide resistance, as well as determine the effect this phenom-
enon has on the vectorial capacity of local mosquitoes to transmit malaria.
Results
Mosquito abundance and species identification. A total of 3962 female An. gambiae s.l. mosquitoes 
were captured from six sites in Maferinyah subprefecture, in Forecariah Prefecture (Senguelen = 766; Yindi = 755; 
Maferinyah Centre I = 660; Madinagbe = 608; Fandie = 608 and Moribayah = 565) over 25 days by manual aspi-
ration from houses and human landing catches (HLCs). A subsample (n = 181) was selected for molecular form 
identification, of which 68% (123/181) and 31% (56/181) were determined to be An. coluzzii (M molecular form) 
and An. gambiaes.s. (S molecular form), respectively; two hybrid forms (An. gambiae-An. coluzzii) were also iden-
tified. While both species were sympatric across Forecariah Prefecture, proportions of An. coluzzii differed among 
study villages (Fisher’s Exact test; p = 0.007), potentially attributable to varying local ecological factors28 (Fig. 1A).
Insecticide resistance intensity. Levels of resistance to four insecticides (alpha-cypermethrin, bendio-
carb, deltamethrin and permethrin) were assessed among 2229 female An. gambiae s.l. mosquitoes, collected 
across six study sites in Forecariah Prefecture (Fig. 1A,C). Local vectors were characterized by intense but highly 
variable pyrethroid resistance, with all populations demonstrating less than 90% mosquito mortality to the diag-
nostic doses (1X) of pyrethroids and most areas containing individuals capable of surviving exposure to 10X these 
insecticide concentrations (Figs 2 and 3). In addition, a subsample of mosquitoes still living following 30 minutes 
of insecticide exposure were held for up to two hours in treated bottles, with more than 30% of vectors capable of 
surviving this extended exposure time in Madinagbe (17/55), Moribayah (19/38), Senguelen (30/82) and Yindi 
(9/27); as compared to alpha-cypermethrin, deltamethrin had higher survival rates (prevalence ratio; PR = 1.60, 
CI = 1.01–2.57, p = 0.049) but permethrin did not (PR = 1.52, CI = 0.94–2.51, p = 0.09). When considering mos-
quitoes surviving two hours of pyrethroid exposure, compared to 1X, there was no evidence of lower survival at 
2X of extended exposure (PR = 0.68, CI = 0.43–1.05, p = 0.08) or 5X (PR = 0.70, CI = 0.43–1.09, p = 0.09) but 
there was significantly lower survival at 10X (PR = 0.26, CI = 0.10–0.54, p = 0.001). The highest levels of pyre-
throid resistance were observed in Moribayah, where mosquito mortality to two times the diagnostic doses of 
deltamethrin and permethrin was 38% and 32%, respectively (Fig. 2). Across all sites, levels of resistance of per-
methrin (PR = 6.67, CI = 2.41–23.76, p = 0.001) and deltamethrin (PR = 3.87, CI = 1.33–14.14, p = 0.02) were 
higher than alpha-cypermethrin.
Figure 1. (A) Map of Forecariah Prefecture, Guinea displaying proportions of An. gambiae s.l. molecular forms 
and susceptibility levels to the diagnostic dose (1X) of alpha-cypermethrin, deltamethrin and permethrin, 
measured using CDC bottle bioassays, at six study sites indicated by stars (Fandie, Madinagbe, Maferinyah 
Centre I, Moribayah, Senguelen and Yindi). Inset map shows the location of Forecariah Prefecture in Guinea. 
(B) Map of Forecariah Prefecture, Guinea displaying frequencies of L1014F, N1575Y and I1527T resistant 
(R) and wild type (S) alleles. (C) Map of Forecariah Prefecture, Guinea displaying susceptibility levels to the 
diagnostic dose (1X) of bendiocarb, measured using CDC bottle bioassays, and frequency of G119S Ace-1 
resistant (R) and wild type (S) alleles. For all maps, legend colours referring to insecticides have darker shading 
denoting average mosquito mortality.
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Figure 2. CDC resistance intensity assay data for three pyrethroid insecticides (alpha-cypermethrin, 
deltamethrin and permethrin) pooled across six study sites in Forecariah Prefecture (Fandie, Madinagbe, 
Maferinyah Centre I, Moribayah, Senguelen and Yindi). Estimates and confidence intervals are from a binomial 
regression model. Mortality below 90% (indicated by the dashed line) indicates the presence of resistance.
Figure 3. Corrected percent mortality (and numbers tested) of Anopheles gambiae s.l. in CDC resistance 
intensity and synergist bioassays conducted in six sites in Forecariah Prefecture, Guinea.
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By comparison, levels of carbamate resistance were low, with complete mosquito susceptibility observed in 
Fandie, Madinagbe, Senguelen and Yindi; possible resistance (95% mosquito mortality) was restricted to two 
adjacent villages (Maferinyah Centre I and Moribayah) (Figs 1C and 2).
For all insecticides, there was no difference in ability to survive exposure between An. coluzzii (n = 123) and 
An. gambiae s.s. (n = 56) (PR = 0.85, CI = 0.70–1.02, p = 0.09 for An. gambiae s.s.) or association with survival 
and physiological status (i.e. blood-fed, unfed, gravid, etc.) (Fisher’s Exact Test; p = 1.00).
Mosquito parity. Of 737 An. gambiae s.l. mosquitoes tested in resistance bioassays that had their ovaries 
inspected for parity, 46% were nulliparous (340/737), i.e. had not laid an egg batch, and 54% (397/737) were 
parous. There was no significant difference in proportion of parous mosquitoes by study village (χ2 = 9.61; 
p = 0.09) or by month tested (χ2 = 2.18; p = 0.14). However, for all three pyrethroids under evaluation, resistant 
mosquitoes were significantly more likely to be nulliparous (PR = 1.15, CI = 1.10–1.21, p < 0.001). This associa-
tion was very similar across insecticides (alpha-cypermethrin: PR = 1.18, CI = 1.06–1.30, p < 0.001; deltamethrin: 
PR = 1.11, CI = 1.005–1.22, p = 0.04; and permethrin: PR = 1.18, CI = 1.05–1.33, p = 0.002). Small sample sizes 
precluded direct comparisons between pyrethroid resistance intensity and parity per insecticide. When consider-
ing resistance levels of all pyrethroids, nulliparous mosquitoes were more likely to be resistant to 2X (PR = 1.31, 
CI = 1.11–1.54, p < 0.001) and 10X (PR = 1.22, CI = 1.01–1.47, p = 0.03) but not to 5X (PR = 1.10, CI = 0.94–1.29, 
p = 0.39). Nulliparous mosquitoes were no more likely to be survivors of exposure to any dose of bendiocarb 
(1X: PR = 2.47, CI = 0.81–7.50, p = 0.16; 2X: PR = 0.50, CI = 0.11–2.32, p = 0.70; 5X: PR = 1.64, CI = 0.53–5.06, 
p = 0.73; 10X: PR = 1.63, CI = 0.59–4.49, p = 0.66).
target site and metabolic mechanisms of resistance. N1575Y mutation screening was undertaken 
in a subset of 388 An. gambiae s.l. and was detected in 13% (49/388) of samples in both An. coluzzii (59%) and 
An. gambiae s.s. (41%); only two homozygote individuals were detected (Fig. 1B and Table 1). The frequency 
of the N1575Y resistant allele did not differ significantly among study districts (Fisher’s Exact Test; p = 0.71) 
(Table 1 and Fig. 1B) (Table 1). There was no significant association between N1575Y allele frequency and ability 
of mosquitoes to survive pyrethroid exposure for 30 minutes (alpha-cypermethrin: PR = 0.85, CI = 0.63–1.13, 
p = 0.42; deltamethrin: PR = 1.06, CI = 0.81–1.37, p = 0.94; and permethrin: PR = 1.26, CI = 0.85–1.87, p = 0.42) 
or two hours (alpha-cypermethrin: PR = 0.26, CI = 0.03–2.04, p = 0.32; deltamethrin: PR = 0.64, CI = 0.19–2.14, 
p = 0.76; and permethrin: PR = 1.33, CI = 0.39–4.55, p = 0.92).
One hundred and twenty-eight base pairs upstream of N1575Y, a second non-synonymous mutation (I1527T) 
was identified among 10% of individuals (11/109); this mutation was not linked to N1575Y and only one indi-
vidual from Maferinyah Centre I had both resistance mutations. All individuals with the I1527T resistant allele 
were heterozygous for this mutation and were identified as An. gambiae s.s. The frequency of the I1527T resistant 
allele did not vary among study villages (Fisher’s Exact test; p = 0.95) (Table 2 and Fig. 1B). There was an associ-
ation between I1527T allele frequency and ability of mosquitoes to survive pyrethroid exposure for 30 minutes 
for permethrin (PR = 2.80, CI = 1.03–7.64, p = 0.04), but not for the other two insecticides (alpha-cypermethrin: 
PR = 0.94, CI = 0.50–1.79, p = 0.995; and deltamethrin: PR = 1.08, CI = 0.52–2.20, p = 0.99). There were too few 
positive mosquitos to analyse associations at two hours.
The L1014F kdr allele was identified in 87% of samples (211/242), with the majority of mosquitoes present-
ing homozygous kdr profiles (83%; 200/242). The frequency of the L1014F kdr resistant allele varied signifi-
cantly among study villages (Fisher’s Exact test; p = 0.0005) (Table 3 and Fig. 1B). There were no associations 
between L1014F kdr allele frequency and ability of mosquitoes to survive insecticide exposure for 30 minutes 
(alpha-cypermethrin: PR = 0.86, CI = 0.49–1.49, p = 0.88; deltamethrin: PR = 1.59, CI = 0.995–2.55, p = 0.054; 
and permethrin: PR = 0.64, CI = 0.41–1.004, p = 0.053). There were not enough mosquitoes to assess associ-
ations between two hour survival and insecticide. When considering L1014F kdr and N1575Y as a single 
resistance haplotype, there was an association between presence of these mutations as compared to only the 
L1014F kdr mutation and ability of mosquitoes to survive permethrin exposure for 30 minutes (PR = 1.92, 
Study Site
Survival 
Status
# Mosquitoes 
tested
Homozygote 
mutation (RR)
Heterozygote 
mutation (RS)
Homozygote 
wild type (SS)
N1575Y allele 
frequency
χ2 Test
P 
valueR S
Fandie
Alive 51 0 8 43 0.08 0.92 0.37 0.543
Dead 12 0 2 10 0.08 0.92 0.1 0.752
Madinagbe
Alive 35 0 3 32 0.04 0.96 0.07 0.791
Dead 5 0 0 5 0 1.0 — —
Maferinyah 
Centre I
Alive 43 0 10 33 0.12 0.88 0.74 0.390
Dead 44 0 5 39 0.06 0.94 0.16 0.690
Moribayah
Alive 38 0 5 33 0.07 0.93 0.19 0.663
Dead 0 0 0 0 — — — —
Senguelen
Alive 73 1 7 65 0.06 0.94 2.14 0.144
Dead 18 0 1 17 0.03 0.97 0.01 0.920
Yindi
Alive 35 0 3 32 0.04 0.96 0.07 0.791
Dead 34 1 3 30 0.07 0.93 4.22 0.040
Table 1. N1575Y allele frequencies in An. gambiae s.l. from six study sites in Forecariah Prefecture, Guinea.
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CI = 1.09–3.37, p = 0.02), but no association with alpha-cypermethrin (PR = 1.05, CI = 0.72–1.54, p = 0.98) or 
deltamethrin (PR = 1.11, CI = 0.78–1.58, p = 0.87). There was no association with survival data at two hours 
(alpha-cypermethrin: PR = 0.42, CI = 0.04–4.48, p = 0.76; deltamethrin: PR = 1.08, CI = 0.18–6.53, p = 1.00; and 
permethrin: PR = 1.58, CI = 0.33–7.50, p = 0.86).
The G119S Ace-1 mutation was detected in 10% of samples (7/67) (Fig. 1C). All individuals with the resistant 
allele were heterozygous for this mutation and were identified as An. gambiae s.s. Frequencies of the G119S Ace-1 
mutation varied significantly among study districts (Fisher’s Exact test; p = 0.029) (Table 4 and Fig. 1C). There 
was a significant association between presence of the G119S Ace-1 mutation and ability of mosquitoes to survive 
30 minute and two hour carbamate exposure (Fisher’s Exact test; p = 0.0047 and Fisher’s Exact test; p = 0.0015, 
respectively).
Across Forecariah Prefecture, significant deviations from Hardy-Weinberg equilibrium were observed for 
L1014F kdr in Madinagbe, Maferinyah Centre I, Senguelen and Yindi (p < 0.005 for all) (Table 3) and for N1575Y 
in Yindi (p = 0.040) but not for any other resistance loci.
Finally, to confirm the potential role of cytochrome P450 enzymes in pyrethroid resistance, mosquitoes col-
lected in Fandie and Senguelen were pre-exposed to piperonyl butoxide (PBO), prior to intensity testing with 
alpha-cypermethrin and deltamethrin, respectively. In both populations, susceptibility was partially restored 
at five times the diagnostic dose of pyrethroids (95% and 89% mosquito mortality to alpha-cypermethrin and 
deltamethrin, respectively) and fully restored at 10X (Fig. 3).
plasmodium falciparum infection and infectivity. The abdomens and head/thoraxes of 484 An. gam-
biae s.l. were screened separately to detect the presence of Plasmodium falciparum oocysts and sporozoites, 
respectively. Overall the proportion of positive mosquitoes for oocysts and sporozoites were 6.0% (29/484) and 
0.2% (1/484), respectively. There was no significant difference in abdomen positive proportions among study 
villages (Fisher’s Exact test; p = 0.21) or molecular forms (n = 179, 63% An. coluzzii and 37% An. gambiae s.s.; PR 
for An. gambiae s.s. = 1.32, CI = 0.28–5.24, p = 0.70). In mosquitoes that survived insecticide exposure, oocyst 
rate was 6.8% (23/340) compared to 4.2% (6/144) in their susceptible counterparts (PR = 1.62, CI = 0.72–4.26, 
p = 0.28). The single sporozoite positive individual was collected from Maferinyah Centre I and died following 
2X alpha-cypermethrin exposure.
Study Site
Survival 
Status
# Mosquitoes 
tested
Homozygote 
mutation (RR)
Heterozygote 
mutation (RS)
Homozygote 
wild type (SS)
I1527T allele 
frequency
χ2 Test
P 
valueR S
Fandie
Alive 15 0 2 13 0.07 0.93 0.08 0.777
Dead 0 0 0 0 — — — —
Madinagbe
Alive 5 0 0 5 0 1.0 — —
Dead 0 0 0 0 — — — —
Maferinyah 
Centre I
Alive 30 0 4 26 0.07 0.93 0.15 0.700
Dead 19 0 2 17 0.05 0.95 0.06 0.806
Senguelen
Alive 17 0 1 16 0.03 0.93 0.02 0.888
Dead 2 0 0 2 — — — —
Yindi
Alive 16 0 2 14 0.06 0.94 0.07 0.791
Dead 5 0 0 5 — — — —
Table 2. I1527T allele frequencies in An. gambiae s.l. from five study sites in Forecariah Prefecture, Guinea.
Study Site
Survival 
Status
# Mosquitoes 
tested
Homozygote 
mutation 
(RR)
Heterozygote 
mutation (RS)
Homozygote 
wild type (SS)
L1014F kdr 
allele frequency
χ2 Test P valueR S
Fandie
Alive 29 29 0 0 1.0 0 — —
Dead 9 9 0 0 1.0 0 — —
Madinagbe
Alive 26 8 3 15 0.63 0.37 14.67 <0.0001
Dead 1 1 0 0 1.0 0 — —
Maferinyah 
Centre I
Alive 41 40 0 1 0.98 0.02 41.00 <0.0001
Dead 29 29 0 0 1.0 0 — —
Moribayah
Alive 6 6 0 0 1.0 0 — —
Dead 0 0 0 0 — — — —
Senguelen
Alive 30 28 0 2 0.93 0.07 30.00 <0.0001
Dead 16 15 0 1 0.94 0.06 16.00 <0.0001
Yindi
Alive 32 21 6 5 0.75 0.25 8.00 0.005
Dead 23 14 2 7 0.65 0.35 15.03 <0.0001
Table 3. L1014F kdr allele frequencies in An. gambiae s.l. from six study sites in Forecariah Prefecture, Guinea.
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Considering the interaction between pyrethroid resistance and P. falciparum infection, there was no signif-
icant relationship between abdomen positivity rate and survival following insecticide exposure in all pooled 
data (PR = 1.36, CI = 0.48–5.52, p = 0.61) or per insecticide (alpha-cypermethrin: Fisher’s Exact test; p = 0.65; 
deltamethrin: Fisher’s Exact test; p = 0.57 and permethrin: Fisher’s Exact test; p = 0.20). Considering the inter-
action between carbamate resistance and P. falciparum infection, survivors of bendiocarb exposure were signif-
icantly more likely to be infected (Fisher’s Exact test; p = 0.049; 4/23 survivors vs. 3/76 susceptible individuals).
No significant associations were observed between presence of target site mutations and abdomen positiv-
ity (N1575Y: Fisher’s Exact test, p = 0.76, I1527T: Fisher’s Exact test, p = 1.00, L1014F kdr: Fisher’s Exact test, 
p = 0.37, and G119S Ace-1: Fisher’s Exact test, p = 0.50).
Discussion
By 2016, resistance to at least one insecticide has been reported from over 80% of malaria endemic countries1, 
representing a threat to the continued efficacy of key malaria control strategies. However, the relative impact of 
decreased mosquito susceptibility on vectorial capacity remains unknown, largely due to a paucity of field data. 
To begin to address this deficit, in an area of high malaria transmission in Guinea, we characterized levels of 
insecticide resistance and age of local vector populations, in combination with molecular identification of resist-
ance markers and detection of malaria infection.
In Forecariah Prefecture, intense pyrethroid resistance was abundant, evidenced by vector populations that 
were not only resistant to ten times the insecticide concentration required to kill susceptible individuals, but were 
also capable of surviving these doses for up to two hours. These observations are of concern given that pyrethroid 
LLINs are the only malaria vector control intervention deployed in this area. The restoration of mosquito sus-
ceptibility following pre-exposure to PBO and the association of mutations in the voltage-gated sodium chan-
nel (VGSC; L1014F kdr-N1575Y haplotype and I1527T) with lower mortality to permethrin suggests that both 
target site mutations and increased activity of P450 monooxygenases are contributing to pyrethroid resistance. 
This finding aligns with reports from Burkina Faso where upregulated detoxification enzymes were responsi-
ble for extreme pyrethroid resistance in An. coluzzii, with N1575Y associated with more limited tolerance to 
deltamethrin29. It has been proposed that N1575Y may compensate for fitness costs incurred by the L1014F kdr 
mutation and provide additional pyrethroid resistance30. The I1527T mutation is located within the III S6 helix 
of the VGSC, adjacent to a predicted pyrethroid/DDT binding site; nearby residues have already been implicated 
in resistance in other medically-important vector species31,32. However, to date, a role for I1527T in phenotypic 
resistance in An. gambiae s.l. has not been confirmed, nor has this mutation been detected in Guinea previously.
Of the three pyrethroid insecticides evaluated, resistance levels were often highest to permethrin, despite all 
mass LLIN campaigns in the country having exclusively distributed deltamethrin-treated products25. This may 
be explained by L1014F kdr playing a larger contributing role to resistance to type I (permethrin) versus type II 
(alpha-cypermethrin and deltamethrin) pyrethroids33. Levels of bendiocarb resistance were comparatively lower, 
which was not unexpected considering IRS is not routinely conducted by the Guinean NMCP. In the case of 
carbamate resistance, the presence of the G119S Ace-1 mutation was highly predictive of bioassay survivorship 
and tolerance to increased exposure times. Previous studies have demonstrated that the G119S Ace-1 substitution 
imposes a high fitness cost34,35 by decreasing affinity of the resistant enzyme for its substrate by more than 60%36; 
heterogeneous or homogeneous duplication of this locus has been proposed to restore activity37. In Forecariah 
Prefecture, frequency of the G119S Ace-1 resistant allele (of undetermined copy number) was low and could be a 
result of selective pressure imposed by unregulated agricultural use of carbamates and organophosphates, which 
were readily available at the local market (S. Irish, personal communication).
Our results demonstrated that pyrethroid resistance was not associated with malaria prevalence in the mos-
quitoes that were tested, with no significant differences observed between Plasmodium infection in susceptible or 
resistant individuals. Our findings contrast with a number of laboratory studies ascribing potential fitness costs 
to insecticide resistance which may have the collateral benefit of reducing malaria transmission16,18–22. However, 
Study Site
Survival 
Status
# Mosquitoes 
tested
Homozygote 
mutation (RR)
Heterozygote 
mutation (RS)
Homozygote 
wild type (SS)
G119S Ace-1 
allele frequency
χ2 Test
P 
valueR S
Fandie
Alive 9 0 1 8 0.06 0.94 0.03 0.862
Dead 7 0 0 7 0 1.0 — —
Madinagbe
Alive 3 0 1 2 0.17 0.83 0.12 0.729
Dead 1 0 0 1 0 1.0 — —
Maferinyah 
Centre I
Alive 17 0 2 15 0.06 0.94 0.07 0.791
Dead 11 0 1 10 0.05 0.95 0.02 0.888
Moribayah
Alive 2 0 2 0 0.5 0.5 2.00 0.157
Dead — — — — — — — —
Senguelen
Alive — — — — — — — —
Dead 9 0 0 9 0.0 1.0 — —
Yindi
Alive — — — — — — — —
Dead 8 0 0 8 0.0 1.0 — —
Table 4. G119S Ace-1 allele frequencies in An. gambiae s.l. from six study sites in Forecariah Prefecture, Guinea.
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in our study, survivors of bendiocarb exposure were significantly more likely to be infected with P. falciparum. 
Pyrethroid exposure has previously been shown to adversely affect P. falciparum development in L1014F kdr 
resistant An. gambiae s.s. in Uganda21, which may explain part of our data, if we assume resistant individuals 
are able to survive contact with LLINs and susceptible vectors are not. Alternative observations have also been 
reported whereby kdr has been shown to potentiate the vector competence of An. gambiae s.s.23, and Plasmodium 
infection has partially restored DDT susceptibility in An. gambiae carrying the kdr mutation38 but also reduced 
the survival of resistant vectors in the absence of insecticide exposure17. The discrepancies between in vitro studies 
and our field data may reflect more generalised fitness variation between laboratory mosquito strains and wild 
populations and/or different underlying resistance mechanisms, e.g. target site mutations vs. increased activity of 
metabolic enzymes, and strongly support the need for additional studies in areas of differing resistance mecha-
nisms and disease transmission intensities.
We examined the impact of resistance on mosquito age as increasing age has been proposed to restore insec-
ticide susceptibility39–46 and insecticide exposure may still reduce resistant vector life-span through delayed mor-
tality effects16. In Forecariah Prefecture, we observed a similar phenomenon, with resistant mosquitoes having 
significantly lower parity rates than their susceptible counterparts.
Elucidating the interaction between insecticide resistance and vectorial capacity is complex and challenging in 
field conditions and a number of limitations were encountered during this study. Adult female mosquitoes were 
sampled using HLCs and via manual aspiration from house walls to maximise the number of individuals avail-
able for bioassay testing. However, these strategies may have introduced a bias in species composition collected; 
previous studies have suggested that proportions of An. gambiae s.s. and An. coluzzii may differ significantly 
between larval and adult spray catches47. We also encountered issues with individuals that did not amplify with 
two sub-species PCR assays48,49, potentially reflecting polymorphisms at the primer binding sites and/or the pres-
ence of a cryptic sub-species; previously a cryptic subgroup GOUNDRY has been reported, with close genetic 
affinities to An. coluzzii and enhanced susceptibility to P. falciparum infection50–52. While use of F1 progeny mos-
quitoes is recommended for resistance testing53,54, to investigate the impact of resistance on Plasmodium infection 
in the vector, it was necessary to sample wild caught adults of undetermined, mixed age and physiological status; 
the latter parameter may have varied between sampling methods, with more fed mosquitoes collected from inside 
houses, compared to unfed, host-seeking mosquitoes in HLCs. As a consequence, mortality in our study may 
have been under-estimated, considering the proposed inverse relationship between vector resistance and age39–45. 
Similarly, blood-feeding among resistant mosquitoes has been suggested to increase insecticide tolerance55, how-
ever, no association between physiological status and resistance was observed in our dataset. Our study would 
have also benefitted from larger sample sizes of mosquitoes tested in bioassays, to statistically power comparisons 
between different resistance intensities. Furthermore, abdomen positive mosquitoes cannot all be assumed to 
become infective sporozoite-transmitters, particularly if vector life-span is reduced; a positive abdomen can also 
reflect a recent feed on an infected individual or the passage of sporozoites to the salivary glands. Finally, manual 
parity dissections have a number of known constraints, including insensitivity, especially in low endemicity areas, 
and inter-operator subjectivity. While every effort was made to consistently bisect individuals, and our reported 
sporozoite rate was low, other studies have demonstrated higher number of sporozoite false positives by PCR 
when abdomens were removed posterior to the junction of the abdomen and thorax56. We also cannot entirely 
discount natural variation in parity, which may have increased over the sampling period at the beginning of the 
rainy season.
Conclusions
These findings present a comprehensive overview of the current levels of insecticide resistance and underlying 
target site mutations present in Maferinyah, Guinea, an area of high malaria transmission. Local mosquito pop-
ulations were intensely resistant to pyrethroids (alpha-cypermethrin, deltamethrin and permethrin), associated 
with high frequencies of the L1014F kdr allele. N1575Y and I1527T mutations in the VGSC gene were present 
at lower levels and may warrant increased surveillance efforts, particularly as L1014F kdr approaches fixation. 
Restoration of mosquito susceptibility following pre-exposure to PBO indicates increased activity of detoxifi-
cation enzymes is also contributing to pyrethroid resistance in this area and requires additional characteriza-
tion. Despite no ongoing vector control activities using carbamates, bendiocarb resistance was observed, and the 
G119S Ace-1 allele was detected in a subset of tolerant individuals. Malaria infection was not associated with pyre-
throid resistance but it was associated with bendiocarb resistance. In general, resistant vectors were younger than 
their susceptible counterparts. Further studies are necessary to investigate the impact of insecticide resistance on 
vector fitness, including mosquito fecundity, egg viability, hatchability and parasite development following an 
infected blood meal.
Methods
study area and mosquito collections. Mosquito collections were undertaken in six villages in the 
Maferinyah sub-prefecture, Forecariah Prefecture (Fandie, Madinagbe, Maferinyah Centre I, Moribayah, 
Senguelen and Yindi), in Southwest Guinea. Deltamethrin-treated LLINs had been distributed as part of a 
national mass campaign in Maferinyah in 2016. Sampling was conducted between 22nd June and 17th July 2017, 
coinciding with the beginning of the long rainy season. Following consent from the household owner, indoor 
resting, female Anopheles mosquitoes were collected from house walls by manual aspiration between 7:00 h and 
12:00 h. In the same villages, mosquitoes were also sampled using HLCs, carried out between 22:00 h and 3:00 h. 
Mosquitoes were stored in cages with access to 10% sugar solution, prior to transport to the Centre de Formation 
et de Recherche en Santé rurale de Maferinyah (CNFRSR) for analysis.
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CDC resistance intensity and synergist bioassays. All bioassays were performed using mosquitoes 
identified morphologically as An. gambiae s.l.57; wild caught females were held for a maximum of 48 hours before 
testing. Centers for Disease Control and Prevention (CDC) resistance intensity bioassays for three pyrethroid 
insecticides (alpha-cypermethrin, deltamethrin and permethrin) were conducted according to published guide-
lines53. Stock solutions of 1, 2, 5 and 10 times the diagnostic dose of insecticide (alpha-cypermethrin: 12.5 μg/
bottle; deltamethrin: 12.5 μg/bottle; and permethrin: 21.5 μg/bottle), were prepared by diluting technical grade 
insecticide in 50 ml of acetone. Bioassays for bendiocarb were conducted using the diagnostic dose (1X: 12.5 
μg/bottle). The inside of each Wheaton 250 ml bottle along with its cap was coated with 1 ml of stock solution 
by rolling and inverting the bottles. In each test, a control bottle was coated with 1 ml of acetone. Following 
coating, bottles were left to dry in a dark box. Approximately 15–25 field-caught adult female An. gambiae s.l. 
of unknown age and mixed physiological status were introduced into each bottle using a mouth aspirator and 
mortality was recorded at 15 minute intervals until all were dead or up to two hours; dead individuals at 30 min-
utes were removed from bottles by aspiration and again after two hours. In each bioassay, a control bottle, coated 
with acetone, was run in parallel. Mortality in control bottles never exceeded 5%. In select sites with significant 
pyrethroid resistance, synergist assays were also conducted by pre-exposing mosquitoes to piperonyl butoxide 
(PBO) for 1 hour (100 µg/bottle) prior to performing pyrethroid bioassays. Multiple replicates were performed 
per insecticide and study village, depending on mosquito availability, and individual surviving (resistant) and 
dead (susceptible) mosquitoes were preserved in RNAlater® (Thermo Fisher Scientific, UK) at −20 °C at the 
London School of Hygiene and Tropical Medicine (LSHTM) and CDC. Prior to molecular analysis, mosquito 
heads/thoraxes were separated from abdomens under a dissecting microscope and stored separately.
parity dissection. Ovarian dissection to determine mosquito parity was performed on ten mosquitoes 
(including both survivors and those that died) selected randomly from each bottle after bioassay completion58. 
The ovaries of each mosquito were dissected on a sterile microscope slide in distilled water, using a binocular 
dissection microscope and physiological status was determined. The ovaries were then examined under a light 
microscope (10X magnification) for the presence of tightly coiled skeins or loose coils, indicative of a nulliparous 
or parous ovary, respectively. On completion of ovarian dissection, head/thoraxes and abdomens of each mos-
quito were stored separately in RNAlater® (Thermo Fisher Scientific, UK) at −20 °C.
Molecular species identification. A subset of susceptible and resistant An. gambiae s.l. mosquitoes from 
all six villages containing both nulliparous and parous individuals were selected for molecular analysis at the 
LSHTM and CDC. Genomic DNA from dissected body parts was extracted per protocol using Qiagen DNeasy 96 
Blood and Tissue kits (Qiagen, UK) at LSHTM or ExtractaTM DNA Prep for PCR-Tissue kits (QuantaBio, USA) 
at CDC.
At LSHTM, molecular species identification was performed using a multiplex TaqMan real time PCR 
assay to detect and discriminate An. gambiae and An. arabiensis59. PCR reactions were prepared using Qiagen 
Quantitect Probes Master mix (Qiagen) with each reaction containing 6.25 µl of master mix, a final concentra-
tion of 0.8 µM of each primer, 0.2 µM of probe An. arabiensis (Cy5), 80 nM of probe An. gambiae (FAM) and 1 µl 
of template DNA for a final reaction volume of 12.5 µl. Prepared reactions were run on a Stratagene Mx30005P 
QPCR system for 10 min at 95 °C, followed by 40 cycles of 95 °C for 25 sec and 66 °C for 60 sec. The increases in 
the species-specific FAM and Cy5 fluorophores were detected in real-time at the end of each cycle and results 
were analysed using Stratagene MxPro QPCR software. Positive controls from gDNA extracted from known An. 
gambiae and An. arabiensis individuals were included in each run, in addition to no template controls (NTCs). 
Sub-samples of individuals from each district confirmed as An. gambiae were further distinguished as An. coluzzii 
or An. gambiae s.s by targeting a SINE200 insertion only present in An. coluzzii48. PCR reactions were prepared 
using Hot Start Taq 2X Master Mix (New England Biolabs, UK) with each reaction containing 12.5 µl of master 
mix, a final concentration of 1 µM of each primer, 2 µl template DNA for a final reaction volume of 25 µl. Prepared 
reactions were amplified using a BIORAD T100 Thermal Cycler for 10 min at 95 °C, followed by 35 cycles of 94 °C 
for 30 sec, 54 °C for 30 sec, 72 °C for 1 min and a final extension of 72 °C for 10 min. PCR products were sepa-
rated and visualised using 2% Egel EX agarose gels (Invitrogen, UK) with SYBR safe and an Invitrogen E-gel iBase 
Real-Time Transilluminator. An. coluzzii individuals with the insertion resulted in a single PCR product of 479 bp 
and An. gambiae s.s. a PCR product of 249 bp.
At CDC, An. coluzzii and An. gambiae s.s. specimens were differentiated by targeting single nucleotide poly-
morphisms (SNPs) present in rDNA49. PCR reactions were prepared using 20–40 ng of DNA, 5X Green GoTaq® 
Reaction Buffer (Promega, USA), 25 mM MgCl2, 2.5 mM of each dNTP, 1 U GoTaq® DNA polymerase and 25 
pmol/μl of primers IMP-UN, AR-3T, GA-3T, IMP-S1 and IMP-M1 in a final volume of 25 µl. PCR reaction condi-
tions were 95 °C for 5 min, followed by 30 amplification cycles (95 °C for 30 sec, 58 °C for 30 sec, 72 °C for 30 sec) 
and a final elongation step at 72 °C for 5 min. Amplified PCR products were visualized on 1.5% agarose gels, 
stained with GelRedTM (Biotium, USA). An. arabiensis Dongola, An. coluzzii AKDR and An. gambiae s.s. RSP-ST 
strains from the Malaria Research and Reference Reagent Resource Center (MR4), were used as positive controls. 
Amplification products of 463 bp and 333 bp or 463 bp and 221 bp were indicative of An. coluzzii or An. gambiae 
s.s., respectively.
Insecticide target site mutation detection. Detection of the L1014F West African kdr mutation was 
performed on a subset of individuals from all six districts according to the adapted protocol for allele-specific 
PCR developed by Martinez-Torres et al.60. At both LSHTM and CDC, PCR reactions were prepared using Hot 
Start Taq 2X Master Mix (New England Biolabs) with each reaction containing 12.5 µl of master mix and variable 
final concentrations of primers (IPCF 0.1 µM, AltRev 0.1 µM, West WT 1 µM, West West 1.1 µM) for a final reac-
tion volume of 25 µl. Prepared reactions were run on a BIO-RAD QPCR system for 5 min at 95˚C, followed by 35 
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cycles of 95˚C for 30 sec, 59˚C for 30 sec and 72˚C for 30 sec and a final extension of 72˚C for 5 min. PCR products 
were separated and visualised using 2% Egel EX agarose gels (Invitrogen) with SYBR safe and an Invitrogen E-gel 
iBase Real-Time Transilluminator. A PCR product of 214 bp indicated the susceptible wild type allele and a PCR 
product of 156 bp indicated the resistant allele. An. coluzzii AKDR and An. gambiae s.s. RSP-ST were used as 
positive and negative controls for L1014F kdr, respectively.
At LSHTM, a larger sub-sample of individuals from all six districts was chosen to be screened for the N1575Y 
mutation (previously shown to have low prevalence in West African populations) using the TaqMan real time 
PCR assay developed by Jones et al.30. PCR reactions were prepared using Qiagen Quantitect Probes Master 
mix (Qiagen) with each reaction containing 10 µl of master mix, a final concentration of 1 µM of each primer 
and 0.5 µM of each probe, 5 µl of PCR grade water and 2 µl of template DNA, for a final reaction volume of 20 µl. 
Prepared reactions were run on a Roche LightCycler 96 System for 15 min at 95˚C, followed by 35 cycles of 94˚C 
for 15 sec and 60˚C for 60 sec. Positive controls from gDNA extracted from known An. gambiae s.s. with or with-
out the N1575Y mutation were included on each run in addition to no template controls (NTCs). PCR results 
were analysed using the LightCycler 96 software (Roche Diagnostics).
At CDC, to detect the N1575Y mutation, a 218 bp fragment of the VGSC channel spanning domains III-IV 
was sequenced. PCR reactions were prepared using 25 µl of 2X AccuStartTM II PCR SuperMix, a final con-
centration of 20 pmol/μl of primers Exon_29_F (5′-AAATGCTCAGGTCGGTAAACA-3′) and Exon_29_R 
(5′-GCCACTGGAAAGAATGGAAA-3′)30 and 2 μl of template DNA, for a final reaction volume of 50 μl. PCR 
reaction conditions were 95 °C for 3 min, followed by 35 amplification cycles (95 °C for 30 sec, 58 °C for 30 sec, 
72 °C for 30 sec) and a final elongation step at 72 °C for 5 min. Amplified PCR products were visualized on 2% aga-
rose gels, stained with GelRedTM (Biotium, USA) and purified using the 96-well MilliporeTM MultiScreenTM HTS 
vacuum manifold system. Bi-directional sequencing was performed using primers Exon_29_F and Exon_29_R 
with the BigDye® Terminator v1.1 Cycle Sequencing Kit (Applied Biosystems, USA) according to the manu-
facturer’s protocol. Sequencing reactions were purified using the Big Dye® XterminatorTM Purification Kit 
(Applied Biosystems, USA), according to the manufacturer’s protocol and data were generated using a 3500xL 
Genetic Analyzer (Applied Biosystems, USA). Sequences were assembled manually in BioEdit v7.0.9.0 sequence 
alignment editor software (Ibis Biosciences, USA) and unambiguous consensus sequences were produced for 
each individual. Consensus sequences are available from GenBank under the accession numbers MH929325 
- MH929433.
The presence of the G119S Ace-1 mutation was determined using PCR restriction fragment length polymor-
phism analysis61. At both LSHTM and CDC, PCR reactions were prepared using Hot Start Taq 2X Master Mix 
(New England Biolabs) with each reaction containing 12.5 µl of master mix, a final concentration of 1 µM of each 
primer, 2 µl template DNA, to a final reaction volume of 25 µl. Prepared reactions were run on a BIO-RAD QPCR 
system for 5 min at 95˚C, followed by 30 cycles of 95˚C for 30 sec, 52˚C for 30 sec and 72˚C for 1 min and a final 
extension of 72˚C for 5 min. PCR products were digested using the AluI restriction enzyme through incuba-
tion at 37˚C for 16 hr followed by 65˚C for 20 min. DNA fragments were visualised on 2% Egel EX agarose gels 
(Invitrogen) with SYBR safe and an Invitrogen E-gel iBase Real-Time Transilluminator. 194 bp undigested PCR 
products indicated the susceptible allele and 74 bp and 120 bp digested fragments indicated the presence of the 
resistant allele. Presence of all three product sizes indicated that the sample was heterozygous.
plasmodium falciparum detection. Bisected mosquito head/thoraxes and abdomens from bioassay indi-
viduals were screened separately for P. falciparum infection, by targeting a 120 bp sequence of the P. falciparum 
cytochrome c oxidase subunit 1 (cox1) mitochondrial gene62. At LSHTM real-time PCR reactions were prepared 
using FastStart SYBR Green Master mix (Roche Diagnostics) with each reaction containing 5 µl of master mix, 
a final concentration of 1 µM of each primer, 1 µl of PCR grade water and 2 µl template DNA, to a final reaction 
volume of 10 µl. Prepared reactions were run on a Roche LightCycler 96 System for 15 min at 95˚C, followed by 
35 cycles of 95˚C for 15 sec and 58˚C for 30 sec. Amplification was followed by a dissociation curve (95˚C for 
10 sec, 65˚C for 60 sec and 97˚C for 1 sec) to ensure the correct target sequence was amplified. Positive controls 
from gDNA extracted from a cultured P. falciparum-infected blood sample (parasitaemia of ~10%) were included 
on each run, in addition to no template controls (NTCs). PCR results were analysed using the LightCycler® 96 
software (Roche Diagnostics).
At CDC, a conventional PCR was used for cox1 detection63. PCR reactions were prepared using 
6.25 µl of2X AccuStartTM II PCR SuperMix, a final concentration of 5 µM of primers COX-IF 
(5′-AGAACGAACGCTTTTAACGCCTG-3′) and COX-IR (5′-ACWGGATGGACTTTATATCCACCATTAAGT-3′)63 
and 2 μl of template DNA, for a final reaction volume of 12.5 μl. PCR reaction conditions were 94 °C for 5 min, followed 
by 40 amplification cycles (94 °C for 1 min, 62 °C for 1 min, 72 °C for 1.5 min) and a final elongation step at 72 °C 
for 10 min. Amplified PCR products were visualized on 2% agarose gels, stained with GelRedTM (Biotium, USA), 
alongside the same positive and negative controls used in the real-time assay. A positive head/thorax or abdomen 
was assumed to indicate the presence of sporozoites or oocysts, respectively.
Data analysis. Percent mosquito mortality for each insecticide dose was interpreted using the WHO criteria: 
98–100% mortality at 30 minutes of exposure indicates ‘susceptibility’, 90–97% mortality suggests ‘possible resist-
ance’ and <90% indicates the presence of ‘resistance’54. Where molecular species ID data were available, results 
are reported for An. coluzzii and An. gambiae s.s. separately; otherwise individuals are referred to as An. gambiae 
s.l. Pearson’s Chi squared tests and Fisher’s exact tests (when sample sizes were small) were used to investigate the 
statistical association between survival by site, allele frequencies, and deviations from Hardy-Weinberg equilib-
rium. Other analyses utilized quasi-Poisson regression to estimate prevalence ratios (PRs) of mosquito survival, 
except the model in Fig. 2, which used a binomial model to ensure confidence intervals did not extend beyond 
100%. Outcomes from pyrethroid bioassays were evaluated separately to carbamate assays, unless otherwise 
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specified. The endpoint of all bioassays was considered to be 30 minutes (the diagnostic time for the insecticides 
under evaluation), unless otherwise specified. All statistical analyses were performed in R version 3.5.164, with the 
level of significance set at α = 0.05.
ethical approval and consent to participate. The study protocol was reviewed and approved by the 
Comite National d’Ethique pour la Recherche en Sante (030/CNERS/17) and the institutional review boards 
(IRB) of the London School of Hygiene and Tropical Medicine (#13612 and #14076) and the Centers for Disease 
Control and Prevention, USA (2018–086); all study procedures were performed in accordance with relevant 
guidelines and regulations. Prior to study initiation, community consent was sought from village leaders and 
written, informed consent was obtained from the heads of all households selected for participation and from all 
fieldworkers who performed HLCs. Study information was provided to participants in French, Susu, Foula and 
Malinké. Fieldworkers participating in human landing catches were provided with doxycycline malaria prophy-
laxis for the duration of the study.
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